Scotch Plains, NJ, United States of America

Joanne Waldstreicher

This inventor holds 20 USPTO granted patents, primarily in Pharmaceutical Treatments. Top assignees: Merck + Co., Inc., Other. Active years: 1996-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joanne Waldstreicher. Retrieved from https://idiyas.com/inventor/joanne-waldstreicher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20

% Patents Active = 90.0

Average Co-Inventor Count = 2.1

ph-index = 8

Forward Citations = 338(Granted Patents)

Company Filing History:

19 out of 4,770

Merck + Co., Inc.

patents

1 out of 834,601

Other

patents

Years Active: 1996-2003

Loading Chart...

Areas of Expertise:

Neurokinin-1 Receptor Antagonist

COX-2 Selective Inhibitor

Chronic Prostatitis

5-Alpha Reductase Inhibitors

In-Vitro Fertilization

Tachykinin Antagonist

Acne Treatment

Polycystic Ovary Syndrome

Preterm Labor

Bone Loss Prevention

Sweat-Related Conditions

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6525073 - Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist (2003-02-25),

2. 6486204 - Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug (2002-11-26),

3. 6403640 - Method for treating chronic prostatitis or chronic pelvic pain syndrome (2002-06-11),

4. 6355649 - Method of treating seborrhea with 5-&agr; reductase inhibitors (2002-03-12),

5. 6352997 - Method of improving in-vitro fertilization (2002-03-05),

6. 6329401 - Enhancement of sleep with a tachykinin antagonist (2001-12-11),

7. 6268377 - Method for treating androgen-related conditions (2001-07-31),

8. 6174892 - Method of treating acne with 5-&agr; reductase inhibitors (2001-01-16),

9. 6054455 - Method for treating or preventing chronic nonbacterial prostatitis and (2000-04-25),

10. 5981543 - Method of treating androgenic alopecia with 5.alpha.-reductase inhibitors (1999-11-09),

11. 5945412 - Methods and compositions for preventing and treating bone loss (1999-08-31),

12. 5942519 - Prevention of precipitated acute urinary retention (1999-08-24),

13. 5935968 - Methods for treating polycystic ovary syndrome (1999-08-10),

14. 5872126 - Methods and compositions for treating preterm labor (1999-02-16),

15. 5824686 - Method of treating androgenic alopecia with 5-alpha reductase inhibitors (1998-10-20),

Title: The Innovative Contributions of Joanne Waldstreicher

Introduction

Joanne Waldstreicher, a prominent inventor based in Scotch Plains, NJ, has made significant strides in the field of medical research and innovation. With an impressive portfolio of 20 patents, she has contributed to advancements in treatments for various health conditions. Her work exemplifies the intersection of science and innovation, impacting countless lives through her inventions.

Latest Patents

Among her most recent patents, Joanne has focused on two critical areas of healthcare. The first patent addresses the prevention or treatment of insomnia using a neurokinin-1 receptor antagonist. This innovative solution targets the alteration of circadian rhythmicity, thereby alleviating circadian rhythm disorders and enhancing the overall quality of sleep. The second patent involves the treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug. This groundbreaking approach presents a compound useful in treating or preventing prostate cancer, improving the efficacy of treatment when used alone or in combination with other medications.

Career Highlights

Throughout her career, Joanne has held pivotal roles in renowned companies, including Merck & Company, Inc. Her expertise and contributions have positioned her as a leader in her field, driving forward innovative solutions for critical healthcare challenges. Her dedication to research and development highlights her commitment to fostering advancements that benefit patients and the medical community.

Collaborations

Joanne's journey in innovation has been enriched through collaborations with notable coworkers such as Keith D Kaufman and Elizabeth Stoner. Working alongside these talented individuals, she has further expanded her knowledge and contributed to the creation of impactful solutions that address pressing health concerns.

Conclusion

Joanne Waldstreicher's contributions to the field of medical innovation are both profound and noteworthy. Her latest patents reflect her commitment to improving patient outcomes and enhancing healthcare solutions. As an accomplished inventor, she continues to inspire future generations of researchers and inventors in their pursuit of groundbreaking advancements.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]